167 related articles for article (PubMed ID: 33848645)
21. Can radical parametrectomy be omitted in occult cervical cancer after extrafascial hysterectomy?
Lu HW; Li J; Liu YY; Liu CH; Xu GC; Xie LL; Wu MF; Lin ZQ
Chin J Cancer; 2015 Aug; 34(9):413-9. PubMed ID: 26253113
[TBL] [Abstract][Full Text] [Related]
22. Do FIGO stage IA and small (≤2 cm) IB1 cervical adenocarcinomas have a good prognosis and warrant less radical surgery?
Al-Kalbani M; McVeigh G; Nagar H; McCluggage WG
Int J Gynecol Cancer; 2012 Feb; 22(2):291-5. PubMed ID: 22080884
[TBL] [Abstract][Full Text] [Related]
23. How important is removal of the parametrium at surgery for carcinoma of the cervix?
Covens A; Rosen B; Murphy J; Laframboise S; DePetrillo AD; Lickrish G; Colgan T; Chapman W; Shaw P
Gynecol Oncol; 2002 Jan; 84(1):145-9. PubMed ID: 11748991
[TBL] [Abstract][Full Text] [Related]
24. Preoperatively Assessable Clinical and Pathological Risk Factors for Parametrial Involvement in Surgically Treated FIGO Stage IB-IIA Cervical Cancer.
Canaz E; Ozyurek ES; Erdem B; Aldikactioglu Talmac M; Yildiz Ozaydin I; Akbayir O; Numanoglu C; Ulker V
Int J Gynecol Cancer; 2017 Oct; 27(8):1722-1728. PubMed ID: 28617687
[TBL] [Abstract][Full Text] [Related]
25. Early cervical cancer and parametrial involvement: is it significant?
Steed H; Capstick V; Schepansky A; Honore L; Hiltz M; Faught W
Gynecol Oncol; 2006 Oct; 103(1):53-7. PubMed ID: 16516279
[TBL] [Abstract][Full Text] [Related]
26. Pre-operative surgical algorithm: sentinel lymph node biopsy as predictor of parametrial involvement in early-stage cervical cancer.
Balaya V; Bresset A; Guani B; Benoit L; Magaud L; Bonsang-Kitzis H; Ngo C; Mathevet P; Lécuru F;
Int J Gynecol Cancer; 2020 Sep; 30(9):1317-1325. PubMed ID: 32753560
[TBL] [Abstract][Full Text] [Related]
27. Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A).
Kato T; Takashima A; Kasamatsu T; Nakamura K; Mizusawa J; Nakanishi T; Takeshima N; Kamiura S; Onda T; Sumi T; Takano M; Nakai H; Saito T; Fujiwara K; Yokoyama M; Itamochi H; Takehara K; Yokota H; Mizunoe T; Takeda S; Sonoda K; Shiozawa T; Kawabata T; Honma S; Fukuda H; Yaegashi N; Yoshikawa H; Konishi I; Kamura T;
Gynecol Oncol; 2015 Apr; 137(1):34-9. PubMed ID: 25662625
[TBL] [Abstract][Full Text] [Related]
28. Safe criteria for less radical trachelectomy in patients with early-stage cervical cancer: a multicenter clinicopathologic study.
Kim HS; Choi CH; Lim MC; Chang SJ; Kim YB; Kim MA; Kim TJ; Park SY; Kim BG; Song YS; Bae DS; Kim JW
Ann Surg Oncol; 2012 Jun; 19(6):1973-9. PubMed ID: 22183162
[TBL] [Abstract][Full Text] [Related]
29. Which factors predict parametrial involvement in early stage cervical cancer? A Turkish multicenter study.
Kilic C; Cakir C; Yuksel D; Tokgozoglu N; Comert GK; Karalok A; Ureyen I; Turkmen O; Boyraz G; Tasci T; Tekin OM; Turan T
Eur J Obstet Gynecol Reprod Biol; 2019 Dec; 243():63-66. PubMed ID: 31675631
[TBL] [Abstract][Full Text] [Related]
30. Clues pointing to simple hysterectomy to treat early-stage cervical cancer.
Coutant C; Cordier AG; Guillo E; Ballester M; Rouzier R; Daraï E
Oncol Rep; 2009 Oct; 22(4):927-34. PubMed ID: 19724875
[TBL] [Abstract][Full Text] [Related]
31. Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy.
Ho CM; Chien TY; Huang SH; Wu CJ; Shih BY; Chang SC
Gynecol Oncol; 2004 May; 93(2):458-64. PubMed ID: 15099962
[TBL] [Abstract][Full Text] [Related]
32. Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy.
Wright JD; Grigsby PW; Brooks R; Powell MA; Gibb RK; Gao F; Rader JS; Mutch DG
Cancer; 2007 Sep; 110(6):1281-6. PubMed ID: 17654664
[TBL] [Abstract][Full Text] [Related]
33. Pretreatment risk factors for parametrial involvement in FIGO stage IB1 cervical cancer.
Yamazaki H; Todo Y; Okamoto K; Yamashiro K; Kato H
J Gynecol Oncol; 2015 Oct; 26(4):255-61. PubMed ID: 26197769
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors affecting disease-free survival in early-stage cervical cancer patients undergoing radical hysterectomy and pelvic-paraaortic lymphadenectomy.
Metindir J; Bilir G
Eur J Gynaecol Oncol; 2007; 28(1):28-32. PubMed ID: 17375702
[TBL] [Abstract][Full Text] [Related]
35. Region-specific Risk Factors for Pelvic Lymph Node Metastasis in Patients with Stage IB1 Cervical Cancer.
Zhao J; Cai J; Wang H; Dong W; Zhang Y; Wang S; He X; Sun S; Huang Y; Huang B; Willborn KC; Jiang P; Wang Z
J Cancer; 2021; 12(9):2624-2632. PubMed ID: 33854622
[No Abstract] [Full Text] [Related]
36. Para-aortic lymph node involvement revisited in the light of the revised 2018 FIGO staging system for cervical cancer.
Ayhan A; Aslan K; Öz M; Tohma YA; Kuşçu E; Meydanli MM
Arch Gynecol Obstet; 2019 Sep; 300(3):675-682. PubMed ID: 31263988
[TBL] [Abstract][Full Text] [Related]
37. Risk factors of pelvic lymph node metastasis in cervical adenocarcinoma following radical hysterectomy and pelvic lymphadenectomy.
Yanaranop M; Sathapornteera N; Nakrangsee S
J Med Assoc Thai; 2014 Nov; 97 Suppl 11():S87-95. PubMed ID: 25509701
[TBL] [Abstract][Full Text] [Related]
38. The Number of Positive Pelvic Lymph Nodes and Multiple Groups of Pelvic Lymph Node Metastasis Influence Prognosis in Stage IA-IIB Cervical Squamous Cell Carcinoma.
Liu Y; Zhao LJ; Li MZ; Li MX; Wang JL; Wei LH
Chin Med J (Engl); 2015 Aug; 128(15):2084-9. PubMed ID: 26228223
[TBL] [Abstract][Full Text] [Related]
39. Risk of Parametrial Spread in Small Stage I Cervical Carcinoma: Pathology Review of 223 Cases With a Tumor Diameter of 20 mm or Less.
Vranes B; Milenkovic S; Radojevic M; Soldatovic I; Kesic V
Int J Gynecol Cancer; 2016 Feb; 26(2):416-21. PubMed ID: 26745697
[TBL] [Abstract][Full Text] [Related]
40. Can parametrectomy be avoided in early cervical cancer? An algorithm for the identification of patients at low risk for parametrial involvement.
Gemer O; Eitan R; Gdalevich M; Mamanov A; Piura B; Rabinovich A; Levavi H; Saar-Ryss B; Halperin R; Finci S; Beller U; Bruchim I; Levy T; Ben Shachar I; Ben Arie A; Lavie O
Eur J Surg Oncol; 2013 Jan; 39(1):76-80. PubMed ID: 23131429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
